Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain

Nov 1, 2014, 00:00
10.1016/j.jval.2014.08.2298
https://www.valueinhealthjournal.com/article/S1098-3015(14)04228-4/fulltext
Title : Cost-Effectiveness Analysis of Bevacizumab, Fotemustine and Extended-Dose Temozolomide in Patients with Recurrent Glioblastoma in Spain
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04228-4&doi=10.1016/j.jval.2014.08.2298
First page : A638
Section Title : Disease-Specific Studies
Open access? : No
Section Order : 1753
Categories :
Tags :
Regions :
ViH Article Tags :